Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psoriasis
Pharma
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Enhertu enters first-line treatment. Daiichi paused an ADC trial following patient deaths. Takeda touts a pair of positive TYK2 readouts. Plus more.
Angus Liu
Dec 19, 2025 8:00am
Relatability, authenticity key to reaching patients, experts say
Sep 10, 2025 2:15pm
Art Garfunkel teams with Sun to break psoriasis sound of silence
Apr 7, 2025 9:30am
Trial results enhance BMS bid for Sotyktu in psoriatic arthritis
Mar 10, 2025 8:38am
JPM25: Takeda touts 6 pipeline assets with big sales potential
Jan 15, 2025 3:17pm
Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says
Dec 23, 2024 11:25am
